InsiderClue
Insiders · Profile

Hughes Thomas E.

Director at Viridian Therapeutics, Inc.\DE · See Remarks at Larimar Therapeutics. Filing since 17 Sep 2015. CIK 0001611048

VRDN Viridian Therapeutics, Inc.\DE Director · 2 trades LRMR Larimar Therapeutics, Inc. See Remarks · 6 trades
Company
Date
Role
Action
Shares
Amount
Of holding
VRDN Viridian Therapeutics, Inc.\DE
11 Oct 2018
Director
Bought
10,000
$47.70K
354%
LRMR Larimar Therapeutics, Inc.
28 Jun 2018
See Remarks
Sold, plan not stated
32,000
$320.00K
20.4%
LRMR Larimar Therapeutics, Inc.
7 Mar 2018
See Remarks
Sold, plan not stated
5,000
$50.00K
3.1%
VRDN Viridian Therapeutics, Inc.\DE
20 Dec 2017
Director
Sold, plan not stated
12,000
$96.00K
80.9%
LRMR Larimar Therapeutics, Inc.
29 Aug 2016
President and CEO
Bought
10,000
$29.99K
18.5%
LRMR Larimar Therapeutics, Inc.
22 Jul 2016
President and CEO
Bought
5,000
$15.10K
10.2%
LRMR Larimar Therapeutics, Inc.
18 Sep 2015
Chief Executive Officer
Sold, plan not stated
23,126
$1.04M
96.6%
LRMR Larimar Therapeutics, Inc.
17 Sep 2015
Chief Executive Officer
Sold, plan not stated
22,500
$900.00K
96.5%
8 decisions on file.